A-1120

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameA-1120

Drug Alias NameA-1120

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionRetinol-binding protein 4 inhibitors

TargetsRetinol-binding protein 4

Therapy Area/IndicationsInsulin Resistance

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsInsulin Resistance

ATC CodeN/A